Michael F Cola - Net Worth and Insider Trading
Michael F Cola Net Worth
The estimated net worth of Michael F Cola is at least $464,708 dollars as of 2024-11-29. Michael F Cola is the President and CEO of Aevi Genomic Medicine Inc and owns about 2,267,859 shares of Aevi Genomic Medicine Inc (GNMX) stock worth over $376,238. Michael F Cola is the Director of Phathom Pharmaceuticals Inc and owns about 9,798 shares of Phathom Pharmaceuticals Inc (PHAT) stock worth over $87,888. Michael F Cola is also the CEO of Avalo Therapeutics Inc and owns about 61 shares of Avalo Therapeutics Inc (AVTX) stock worth over $583. Details can be seen in Michael F Cola's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael F Cola has not made any transactions after 2020-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael F Cola
Michael F Cola Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael F Cola owns 6 companies in total, including Avalo Therapeutics Inc (AVTX) , Aevi Genomic Medicine Inc (GNMX) , and Sage Therapeutics Inc (SAGE) among others .
Click here to see the complete history of Michael F Cola’s form 4 insider trades.
Insider Ownership Summary of Michael F Cola
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2020-06-09 | director & Chief Executive Officer |
| GNMX | Aevi Genomic Medicine Inc | 2020-06-09 | director & Chief Executive Officer |
| SAGE | Sage Therapeutics Inc | 2014-09-11 | director |
 | | 2019-10-29 | director |
| | 2018-06-13 | director |
| | 2004-01-12 | Managing Director |
Michael F Cola Latest Holdings Summary
Michael F Cola currently owns a total of 3 stocks. Among these stocks, Michael F Cola owns 2,267,859 shares of Aevi Genomic Medicine Inc (GNMX) as of December 5, 2019, with a value of $376,238 and a weighting of 80.96%. Michael F Cola owns 9,798 shares of Phathom Pharmaceuticals Inc (PHAT) as of October 29, 2019, with a value of $87,888 and a weighting of 18.91%. Michael F Cola also owns 61 shares of Avalo Therapeutics Inc (AVTX) as of June 9, 2020, with a value of $583 and a weighting of 0.13%.
Latest Holdings of Michael F Cola
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GNMX | Aevi Genomic Medicine Inc | 2019-12-05 | 2,267,859 | 0.17 | 376,238 |
| PHAT | Phathom Pharmaceuticals Inc | 2019-10-29 | 9,798 | 8.97 | 87,888 |
| AVTX | Avalo Therapeutics Inc | 2020-06-09 | 61 | 9.55 | 583 |
Holding Weightings of Michael F Cola
Michael F Cola Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael F Cola has made a total of 1 transactions in Aevi Genomic Medicine Inc (GNMX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aevi Genomic Medicine Inc is the acquisition of 2,049,376 shares on December 5, 2019, which cost Michael F Cola around $266,419.
According to the SEC Form 4 filings, Michael F Cola has made a total of 0 transactions in Phathom Pharmaceuticals Inc (PHAT) over the past 5 years. The most-recent trade in Phathom Pharmaceuticals Inc is the acquisition of 9,798 shares on October 29, 2019, which cost Michael F Cola around $186,162.
According to the SEC Form 4 filings, Michael F Cola has made a total of 2 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 35 shares on June 9, 2020, which cost Michael F Cola around $250,000.
Insider Trading History of Michael F Cola
- 1
Michael F Cola Trading Performance
GuruFocus tracks the stock performance after each of Michael F Cola's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael F Cola is 12.82%. GuruFocus also compares Michael F Cola's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael F Cola within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael F Cola's insider trading performs compared to the benchmark.
Performance of Michael F Cola
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.69 | | | | | |
| Relative Return to S&P 500(%) | 6.79 | | | | | |
Michael F Cola Ownership Network
Michael F Cola Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Michael F Cola is the director & Chief Executive Officer of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Michael F Cola made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 34,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 1,000 shares, with a net purchase of 1,000 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 1,164 shares were bought by its insiders, resulting in a net sale of 14,184 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Michael F Cola Mailing Address
Above is the net worth, insider trading, and ownership report for Michael F Cola. You might contact Michael F Cola via mailing address: 435 Devon Park Building 800, Wayne Pa 19087-1945.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
